Clinical Trials in New York

Showing 10341-10360 of 19,464 trials

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

NCT00171249

The objectives of Part 1 of the study were: * To determine the rate of hematologic response (HR) lasting ≥4 weeks in participants with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the accelerated phase (AP). * To evaluate duration of HR, overall survival, cytogenetic response (CyR), time to blast crisis in CML participants in the AP, improvement of symptomatic parameters, tolerability and safety of STI571 treatment. The objective of the extension (Part 2) was: -To enable participants to have access to study drug and continue study treatment and to decrease data collection to include only overall survival and serious adverse events.

Philadelphia Positive Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia

Novartis Pharmaceuticals293 participantsStarted Aug 1999

Boston, Massachusetts, United States • New York, New York, United States • Portland, Oregon, United States +9 more locations

SUSPENDED< 1 mile

Natural History Study of MNGIE

NCT04245917

Non-interventional, prospective, multicenter, natural history study of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

Mitochondrial Neurogastrointestinal Encephalomyopathy

Entrada Therapeutics, Inc.60 participantsStarted Aug 2020

Aurora, Colorado, United States • New York, New York, United States • Houston, Texas, United States +2 more locations

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

Natural History Study of MNGIE

Find Trials by Condition in New York

Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages

Optimizing the Tobacco Cessation Clinical Decision Support Tool.

Testing the Efficacy of a Post-discharge Call Program on the Rate of Readmission

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Phase 2/3 Study of IGSC, 20% in PIDD

Remote Bimanual Virtual Rehabilitation Post CVD

Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers

Evaluation of Brain Activity Changes After a Behavior Change Weight Loss Intervention

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

Breast Mesh Used in Two-staged Breast Reconstruction

Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A